Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
138
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
+2.44M
-
Total reported value, excl. options
-
$172M
-
Value change
-
+$17.9M
-
Put/Call ratio
-
0.07
-
Number of buys
-
83
-
Number of sells
-
-47
-
Price
-
$6.90
Significant Holders of Niagen Bioscience, Inc. - COM NEW (NAGE) as of Q1 2025
159 filings reported holding NAGE - Niagen Bioscience, Inc. - COM NEW as of Q1 2025.
Niagen Bioscience, Inc. - COM NEW (NAGE) has 138 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
.
Largest 10 shareholders include BlackRock, Inc. (3.62M shares), VANGUARD GROUP INC (3.54M shares), Tieton Capital Management, LLC (1.99M shares), D. E. Shaw & Co., Inc. (1.28M shares), GEODE CAPITAL MANAGEMENT, LLC (1.18M shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (990K shares), STATE STREET CORP (927K shares), Connor, Clark & Lunn Investment Management Ltd. (744K shares), Qube Research & Technologies Ltd (710K shares), and MILLENNIUM MANAGEMENT LLC (601K shares).
This table shows the top 138 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.